3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Uterine Cervical Neoplasms
12
Ovarian Neoplasms
3
Gestational Trophoblastic Disease
2
Endometrial Neoplasms
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Recurrence
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Cervical Cancer Metastatic
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Cervical Cancer
1
Interventions
Methotrexate
6
Dactinomycin
6
Drug Therapy
4
camrelizumab
3
Vacuum Curettage
3
Flow Cytometry
3
toripalimab
2
pembrolizumab
2
apatinib
2
Psychiatric Rehabilitation
2
Methylprednisolone
2
Leucovorin
2
Immunologic Techniques
2
Filgrastim
2
Etoposide
2
Cyclophosphamide
2
Carboplatin
2
Alemtuzumab
2
zimberelimab
1
sargramostim
1
dostarlimab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carotuximab
1
aldesleukin
1
Vincristine
1
Thrombopoietin
1
Tacrolimus
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Gestational Trophoblastic Disease
×
toripalimab
×
Gynecologic
×
Clear all
NCT06028672
2025-02-06
TA56
Peking Union Medical College Hospital
Phase NA
Recruiting
40 enrolled
NCT06020755
2024-12-31
TA7
Peking Union Medical College Hospital
Phase 2
Recruiting
17 enrolled